Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 1, 2006
May 8, 2024
84223118-f6e6-4029-b7dc-665bd6fd62dd
Related Documents
Considerations for Plasmid DNA Vaccines for Infectious Disease Indications: Guidance for Industry
Guidance DocumentNovember 1, 2007Center for Biologics Evaluation and Research
Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines: Guidance for Industry
Guidance DocumentMay 31, 2007Center for Biologics Evaluation and Research
Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials: Guidance for Industry
Guidance DocumentSeptember 27, 2007Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox